|
|
Article: Testing for Coccidioidomycosis among patients with community-acquired pneumonia.(RESEARCH)
- Article from:
- Emerging Infectious Diseases
- Article date:
- July 1, 2008
- Author:
CopyrightCOPYRIGHT 2008 U.S. National Center for Infectious Diseases. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Coccidioidomycosis is a common cause of community-acquired pneumonia (CAP) in disease-endemic areas. Because testing rates influence interpretation of reportable-disease data and quality of CAP patient care, we determined the proportion of CAP patients who were tested for Coccidioides spp., identified testing predictors, and determined the proportion of tested patients who had positive coccidioidomycosis results. Cohort studies to determine the proportion of ambulatory CAP patients who were tested in 2 healthcare systems in metropolitan Phoenix found testing rates of 2% and 13%. A case--control study identified significant predictors of testing to be age [greater than or ...